How long does Phencyclidine (PCP) stay in the system?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Detection Duration of Phencyclidine (PCP) in the Body

PCP can be detected in urine for approximately 1-4 days after a single use, but in chronic users, detection extends to approximately 1 week or longer after last use. 1

Detection Windows by Biological Matrix

Urine Detection (Most Clinically Relevant)

  • Single dose: Detection window of 1.5 to 4 days 1
  • Chronic users: Approximately 1 week after last use, with extreme cases showing even longer detection periods 1
  • Urine provides the longest practical detection window among commonly tested fluids 1

Blood/Plasma Detection

  • Most drugs of abuse, including PCP, can be detected at low nanogram per milliliter levels for 1 to 2 days in blood or plasma 1
  • Maximum plasma PCP concentrations of 2.7 to 2.9 ng/ml are observed after 1-mg doses 2
  • Blood/plasma ratios are approximately 1.0 with plasma protein binding around 65% 2

Oral Fluid (Saliva) Detection

  • Detection window of 5-48 hours at low nanogram per milliliter levels 1
  • Parent drug can be found in saliva 2

Other Matrices

  • Hair: Provides the longest detection time overall, though specific timeframes for PCP are not detailed in the available evidence 1
  • Sweat: Detection possible but shorter than urine 1

Pharmacokinetic Factors Affecting Detection

Elimination Half-Life

  • Terminal phase half-life averages 21 ± 3 hours (harmonic mean 17 hours, range 7-46 hours) 2
  • This relatively long half-life contributes to extended detection windows, particularly in chronic users 2

Metabolism and Excretion

  • PCP is cleared principally by metabolism (91% of total clearance) rather than renal excretion 2
  • After a 1-mg dose, 72.8% of the drug and metabolites are recovered in urine, with only 16% as unchanged PCP 2
  • Approximately 31% consists of enzymatically hydrolyzable conjugates of hydroxylated metabolites 2
  • Fecal excretion is minimal (3.4-4.7%) 2
  • Oral bioavailability is estimated at 72% 2

Volume of Distribution

  • Large volume of distribution averaging 6.2 ± 0.3 L/kg 2
  • This extensive tissue distribution contributes to prolonged detection in chronic users 2

Clinical Considerations

Factors Prolonging Detection

  • Chronic use: The most significant factor extending detection beyond the typical 1-4 day window 1
  • Dose: Higher doses extend detection times 1
  • Urine pH and concentration: Can affect detection sensitivity 1
  • Individual metabolic variation: Renal and metabolic clearance varies between individuals 1

Testing Method Sensitivity

  • Detection times depend heavily on the sensitivity of the analytical method used 1
  • Modern LC-MS/MS and LC-HRMS methods can detect PCP at very low concentrations 3
  • Commercial immunoassay test kits based on antigen-antibody interactions are available for screening 4

Important Caveats

The detection window can be significantly longer in heavy, chronic users compared to single-use scenarios, making it essential to consider use patterns when interpreting toxicology results 1. The wide range in elimination half-life (7-46 hours) also means substantial individual variation exists 2.

Acidification of urine may increase PCP clearance during acute intoxication treatment, potentially shortening detection windows 4, though this is primarily a therapeutic consideration rather than a forensic one.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.